BW Gestao de Investimentos Ltda. Invests $8.08 Million in CVS Health Co. (NYSE:CVS)

BW Gestao de Investimentos Ltda. bought a new stake in CVS Health Co. (NYSE:CVS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 180,000 shares of the pharmacy operator's stock, valued at approximately $8,080,000. CVS Health accounts for about 0.3% of BW Gestao de Investimentos Ltda.'s portfolio, making the stock its 28th biggest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Ridgewood Investments LLC lifted its holdings in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in CVS Health during the 4th quarter valued at about $28,000. Hopwood Financial Services Inc. bought a new stake in CVS Health during the fourth quarter worth about $29,000. Financial Perspectives Inc increased its holdings in shares of CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares in the last quarter. Finally, Compass Planning Associates Inc acquired a new position in shares of CVS Health in the 4th quarter worth approximately $37,000. Institutional investors own 80.66% of the company's stock.

Insider Activity

In other news, Director Michael F. Mahoney purchased 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is owned by corporate insiders.

CVS Health Stock Up 0.9 %

Shares of CVS stock traded up $0.56 on Wednesday, hitting $66.79. 9,279,324 shares of the stock were exchanged, compared to its average volume of 11,434,105. The business has a 50-day moving average of $66.82 and a 200 day moving average of $58.85. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The firm has a market capitalization of $84.21 billion, a P/E ratio of 18.25, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the business earned $1.31 EPS. Equities analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.98%. CVS Health's dividend payout ratio is 63.48%.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Evercore ISI lifted their price objective on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Wolfe Research upped their price target on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Finally, Piper Sandler raised their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $74.81.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.